Why you should feel optimistic about the future of healthcare
September 14, 2021 | Medtech, Pharma, healthcare
It has been a difficult year to remain hopeful for those working in the healthcare industry, but there are some reasons to remain optimistic.
Optimists have had a difficult time over the past year. However, there are many reasons to be hopeful about the future of healthcare.
The next decade will see a major transformation in health systems and healthcare, driven in part by growing digital health capabilities and medical innovations. Here are some innovations and technologies that have me excited for the future.
A cure for type 1 diabetes
The word ‘cure’ is a bit of a rarity in healthcare, with treatments predominantly designed to manage conditions or their symptoms; a cure is the holy grail.
For Doug Melton, a Harvard biologist whose children have type 1 diabetes, just managing their condition was not enough. He began work 10 years ago using stem cells to try and replicate human beta cells, which produce insulin. His company was bought out and recently launched a clinical trial of VX-880, a stem cell-derived beta cell therapy, in people with type 1 diabetes.
A CURE for type 1 diabetes is simply incredible, potentially saving people from a lifetime of careful eating, insulin injections and blood glucose tests.
Precision medicine
Precision medicine takes into account a person’s individual genetics, environment and lifestyle to match them to a treatment that will give them the best possible outcomes. Precision medicines already exist; imatinib works to treat leukaemia only when the cancer cells have a particular genetic makeup, Sotorasib targets a specific mutation in people with lung cancer to halt tumour growth, and there are many more examples.
In the future we’re going to see more and more precision medicines, as we move away from a one-size-fits-all approach, and step towards a world where clinicians can accurately predict which treatments will work best for different people. I can’t wait to live in a time when we will have a specific treatment for different forms of a condition, and every patient has the best chance of managing or even curing their disease.
Nanomedicine
You could be forgiven for reading that heading and thinking I’d read a few too many science fiction novels recently, but stay with me. Nanomedicine is the medical application of nanotechnology, which operates at the atomic or molecular scale. This technology has the potential for a diverse range of uses in healthcare, from imaging and diagnosis to drug targeting and delivery.
It’s not something that’s ridiculously out of reach either. There are companies that have developed and begun testing this technology. CytImmune Sciences recently completed a Phase I trial using gold nanoparticles to target drug delivery to tumours; BlueWillow Biologics has developed nanotech that fights viruses and bacteria. The fact that nanomedicine is no longer a far-fetched dream is hugely exciting and it will be fascinating to watch our capabilities in this area grow.
Feeling more positive yet?
Hopefully these examples have reminded you of what an incredible age we live in for medical innovation as we make things that weren’t dreamed of 20 years ago into our reality. Of course, there are countless more technologies and therapies on the horizon that probably deserve to be listed here too.
This content was provided by Say Communications
Company Details
Latest Content from Say Communications
B2B social media: a spring 2016 review
Is your social media strategy on point? Take a look at the latest trends in B2B social media.
Why everyone is standing-up to the sitting-down problem
Are the exercise gurus really onto something? Find out how workplace fitness can boost your health and reduce your bum, while helping you become more productive throughout the day.
No one needs to go hungry in London
Our Say blogger returns to St James’s Church Winter Shelter for an overnight shift for the West London Day Centre charity.
Should We Care About Rare Diseases? By Alastair Kent
Alastair Kent, OBE, the Director of Genetic Alliance UK and chair of Rare Disease UK tells us why it’s so important to care about rare disease and why we should...
Breaking Down the Barriers to Behaviour Change by Patrick Ladbury
Patrick Ladbury, the Director at the NSMC delves further into the barriers to behaviour change, and offers us tricks of the trade in his second instalment.
Changing faces – overcoming the taboo of marketing to a mature audience
Our new blog highlights the challenges for communicating to consumers who are 50+ and how they must be tackled in order to create marketing opportunities.
I want to ride my bicycle, I want to ride my bike!
Our team’s motivations behind cycling on two static bikes for 282 miles - the equivalent of London to Paris, to raise money for British Dupuytren’s Society. Please donate!
Life hacks to stay safe online
Conducting our cyber lives, we easily forget and probably ignore the dangers our careless online behaviour can cause. Our new blog provides advice on personal IT to help you to...
How will child public health be prioritised? by Alison Wall
Public health strategist Alison Wall stresses the importance of child public health as a commissioning responsibility.
Cold weather is yet to start at St James’s Winter Shelter
First shift at the St James’s Church Winter Shelter, cooking dinner for fifteen of London’s homeless, and encourages us all to consider volunteering this winter.